Volume 12, Issue 1 (Winter 2023)                   J Occup Health Epidemiol 2023, 12(1): 4-11 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rezakhani L, Khazaei M, Vaziri S, Khosravi Shadmani F. Mortality among COVID-19 Patients with Different Comorbidities in Kermanshah, West of Iran (2020). J Occup Health Epidemiol 2023; 12 (1) :4-11
URL: http://johe.rums.ac.ir/article-1-620-en.html

Related article in
Google Scholar

1- Assistant Prof., Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; Dept. of Tissue Engineering, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. , leila_rezakhani@yahoo.com
2- Professor, Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; Dept. of Tissue Engineering, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3- Professor, Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
4- Assistant Prof., Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Article history
Received: 2022/07/11
Accepted: 2022/12/31
ePublished: 2023/03/27
Subject: Epidemiology
Abstract:   (588 Views)
Background: Cancer and underlying diseases in the covid-19 pandemic created more problems for those affected by the coronavirus. This study aimed to evaluat patients' mortality and related factors based on underlying diseases in people with COVID-19.
Materials and Methods: This descriptive study was performed on patients with COVID-19 admitted to Kermanshah hospital from February 22, 2020, to September 22, 2021. Clinical information was obtained from medical records and patient's history was extracted from the case documentation. The mortality and case fatality rates in hospitalized COVID-19 cases were calculated. Analysis of logistic regression models was used to identify prognostic factors of death.
Results: Out of 55813 patients admitted to the hospital due to covid-19 on the mentioned date, 4260 died. Furthermore, the most common underlying disease in hospitalized patients due to covid 19 was hypertension (11.4%). The prevalence of cancers was 1.4%. The highest in-hospital case fatality rate was chronic kidney disease (CKD) (21.3%) and cancer (16.6%). In addition, among the underlying diseases, the odds ratio of CKD was 2.12 (CI90%= 1.38- 3.26), and cancers were 2.06 (CI95%= 1.25- 3.37), the most important underlying diseases for odds of death.
Conclusion: The prevalence of hypertension (HTN) and cardiovascular diseases (CVD) was higher in hospitalized patients with COVID-19 than patients with other underlying diseases. However, patients with CKD and cancer had a higher odds ratio for death. Therefore, attention to managing patients with CKD and cancers should be seriously considered and followed.

 
Full-Text [PDF 367 kb]   (207 Downloads)    

References
1. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. [DOI] [PMID] [PMCID]
2. South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020;318(5):H1084-90. [DOI] [PMID] [PMCID]
3. Papadokostaki E, Tentolouris N, Liberopoulos E. COVID-19 and diabetes: What does the clinician need to know? Prim Care Diabetes. 2020;14(5):558-63. [DOI] [PMID] [PMCID]
4. Liang W, Guan W, Chen R, Wang W, Li J, Xu K,et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7 [DOI] [PMID]
5. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. [DOI] [PMID] [PMCID]
6. He X, Lau EH, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672-5. [DOI] [PMID]
7. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020;25(6):e936-45. [DOI] [PMID] [PMCID]
8. Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904-13. [DOI] [PMID]
9. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-6. [DOI] [PMID]
10. Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol. 2020;127:104378. [DOI] [PMID] [PMCID]
11. COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention. Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea. Osong Public Health Res Perspect. 2020;11(2):85-90. [DOI] [PMID] [PMCID]
12. Emami A, Javanmardi F, Akbari A, Moghadami M, Bakhtiari H, Falahati F, et al. Characteristics of deceased patients with CoVID-19 after the first peak of the epidemic in Fars province, Iran. Infect Ecol Epidemiol. 2020;10(1):1781330. [DOI] [PMID] [PMCID]
13. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524. [DOI] [PMID] [PMCID]
14. Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X, et al. Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):748-55. [DOI] [PMID] [PMCID]
15. Curigliano G. Cancer Patients and Risk of Mortality for COVID-19. Cancer Cell. 2020;38(2):161-3. [DOI] [PMID] [PMCID]
16. Erdal GS, Polat O, Erdem GU, Korkusuz R, Hindilerden F, Yilmaz M,et al. The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study. Int J Clin Oncol. 2021;26(5):826-34. [DOI] [PMID] [PMCID]
17. Meng Y, Lu W, Guo E, Liu J, Yang B, Wu P, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020;13(1):75. [DOI] [PMID] [PMCID]
18. Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Analysis of 92 deceased patients with COVID-19. J Med Virol. 2020;92(11):2511-5. [DOI] [PMID] [PMCID]
19. Chaturvedi R, Lui B, Aaronson JA, White RS, Samuels JD. COVID-19 complications in males and females: recent developments. J Comp Eff Res. 2022;11(9):689-98. [DOI] [PMID] [PMCID]
20. Khalil HPSA, Jummaat F, Yahya EB, Olaiya NG, Adnan AS, Abdat M, et al. A Review on Micro- to Nanocellulose Biopolymer Scaffold Forming for Tissue Engineering Applications. Polymers (Basel). 2020;12(9):2043. [DOI] [PMID] [PMCID]
21. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA pediatrics. 2021;175(8):817-26. [DOI] [PMID] [PMCID]
22. Choi KW, Chau TN, Tsang O, Tso E, Chiu MC, Tong WL, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139(9):715-23. [DOI] [PMID]
23. Kang YJ. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease. Disaster Med Public Health Prep. 2020;14(3):384-6. [DOI] [PMID] [PMCID]
24. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. [DOI] [PMID] [Google Scholar]
25. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5. [DOI] [PMID] [PMCID]
26. Hong K-H, Choi J-P, Hong S-H, Lee J, Kwon J-S, Kim S-M, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 2018;73(3):286-9. [DOI] [PMID]
27. CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-6. [DOI] [PMID] [PMCID]
28. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198. [DOI] [PMID]
29. Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakPatients with Cancer in SARS-COV-2 Infection. Cancer Discov. 2020;10(6):783-91. [DOI] [PMID] [PMCID]
30. Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemCase Fatality Rate of Cancer Patients with COVID-19. Cancer Discov. 2020;10(7):935-41. [DOI] [PMID] [PMCID]
31. Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, et al. Determinants of severity in cancer patients with COVID-19 illness. Nat Med. 2020;26(8):1218. [DOI] [PMID] [PMCID]
32. Venkatesulu BP, Chandrasekar VT, Girdhar P, Advani P, Sharma A, Elumalai T, et al. A systematic review and meta-analysis of cancer patients affected by a novel coronavirus. JNCI Cancer Spectr. 2021;5(2):pkaa102. [DOI] [PMID] [PMCID]
33. Jee J, Foote MB, Lumish M, Stonestrom AJ, Wills B, Narendra V, et al. Chemotherapy and COVID-19 outcomes in patients with cancer. J Clin Oncol. 2020;38(30):3538-46. [DOI] [PMID] [PMCID]
34. Elkrief A, Desilets A, Papneja N, Cvetkovic L, Groleau C, Lakehal YA, et al. High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study. Eur J Cancer. 2020;139:181-7. [DOI] [PMID] [PMCID]
35. Saini KS, Tagliamento M, Lambertini M, McNally R, Romano M, Leone M, et al. Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies.Eur J Cancer. 2020;139:43-50. [DOI] [PMID] [PMCID]
36. Chavez-MacGregor M, Lei X, Zhao H, Scheet P, Giordano SH. Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol. 2022;8(1):69-78. [DOI] [PMID] [PMCID]
37. Lee LY, Cazier J-B, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919-26. [DOI] [PMID]
38. Tu J, Mo X, Zhang X, Xun J, Chen X, Liu Y, et al. Effects of different corticosteroid therapy on severe COVID-19 patients: a meta-analysis of randomized controlled trials. Expert Rev Respir Med. 2022;16(1):79-89. [DOI] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Occupational Health and Epidemiology

Designed & Developed by : Yektaweb